KYNB Kyntra Bio, Inc.
Kyntra Bio, Inc. (KYNB) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: May 14, 2026 , by Wettig Thane .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Wettig Thane | CEO | Buy | 2,800 | $7.09 | $19.9K | 27,203 | |
| Wettig Thane | CEO | Buy | 2,700 | $9.10 | $24.6K | 24,939 | |
| Wettig Thane | CEO | Buy | 1,000 | $9.18 | $9.2K | 22,239 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.